Dataset from Open Label, Multinational, Multicenter, Real World Treatment Study of Single Agent AZD9291 for Patients With Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR) T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Who Have Received Prior Therapy With an EGFR Tyrosine Kinase Inhibitor (EGFR-TKI)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008159
下载链接
链接失效反馈官方服务：
资源简介：
The aim of this study is to assess the efficacy and safety of single agent AZD9291 in a real
world setting in adult patients with advanced or metastatic, epidermal growth factor receptor
(EGFR) T790M mutation-positive Non-Small Cell Lung Cancer (NSCLC), who have received prior
EGFR-tyrosine kinase inhibitor (TKI) therapy.
创建时间：
2025-04-10
